Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/19/19 → 1/13/22 |
Funding
- Seres Therapeutics Incorporated: $26,366.00
ECO-RESET: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to-Moderate Ulcerative Colitis
- Flomenhoft, Deborah (PI)